Literature DB >> 9556079

Uroguanylin: gene structure, expression, processing as a peptide hormone, and co-storage with somatostatin in gastrointestinal D-cells.

H J Mägert1, M Reinecke, I David, H R Raab, K Adermann, H D Zucht, O Hill, R Hess, W G Forssmann.   

Abstract

Guanylin/GCAP-I and uroguanylin/GCAP-II are two structurally related peptides which play an important role in the regulation of water/electrolyte balance within the gut. In order to enable the investigation and comparison of both peptide hormones at the genomic level, we decided to clone the corresponding genes. The human gene for guanylin/GCAP-I and its 5'-flanking region have been described recently. Here, we report the three exon/two intron structure of the human uroguanylin/GCAP-II gene and its localization on chromosome 1 p35-34, as determined by radiation hybrid mapping. Together with data obtained for the guanylin/GCAP-I gene we show that these genes are localized in the same chromosomal area with other guanlyl cyclase-activating peptides like ANP etc. Northern hybridization revealed that the expression of the uroguanylin/GCAP-II gene is highest in the intestinal mucosa, especially in the ileum and colon. By means of polymerase chain reaction (PCR), an expression was also observed in the stomach where no guanylin/GCAP-I expression is detectable. Using immunohistochemical methods, uroguanylin/GCAP-II immunoreactive material was distinctly localized in D-type gastric and intestinal endocrine cells. Although the comparable data on the genomic organisation of both peptide hormones verify their high degree of relationship, this finding indicates a special task of uroguanylin/GCAP-II within the stomach, such as regulatory functions in gastric secretion. The redundant expression of the GCAP/GC-C system in the small and large intestine, however, is as yet unclear.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9556079     DOI: 10.1016/s0167-0115(97)01078-1

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  12 in total

1.  An enteroendocrine cell-based model for a quiescent intestinal stem cell niche.

Authors:  I R Radford; P N Lobachevsky
Journal:  Cell Prolif       Date:  2006-10       Impact factor: 6.831

Review 2.  Mechanisms of actions of guanylin peptides in the kidney.

Authors:  Aleksandra Sindić; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2005-06-11       Impact factor: 3.657

Review 3.  Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C.

Authors:  Arie B Vaandrager
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

4.  Gastrin, somatostatin, G and D cells of gastric ulcer in rats.

Authors:  Feng-Peng Sun; Yu-Gang Song; Wei Cheng; Tong Zhao; Yong-Li Yao
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

5.  The rat kidney contains high levels of prouroguanylin (the uroguanylin precursor) but does not express GC-C (the enteric uroguanylin receptor).

Authors:  Xun Qian; Nicholas G Moss; Robert C Fellner; Bonnie Taylor-Blake; Michael F Goy
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-24

6.  Identification and functional characterization of hemorphins VV-H-7 and LVV-H-7 as low-affinity agonists for the orphan bombesin receptor subtype 3.

Authors:  Hans-Peter Lammerich; Annette Busmann; Christian Kutzleb; Martin Wendland; Petra Seiler; Claudia Berger; Peter Eickelmann; Markus Meyer; Wolf-Georg Forssmann; Erik Maronde
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

Review 7.  Pendrin, a novel transcriptional target of the uroguanylin system.

Authors:  Julia Rozenfeld; Osnat Tal; Orly Kladnitsky; Lior Adler; Edna Efrati; Stephen L Carrithers; Seth L Alper; Israel Zelikovic
Journal:  Cell Physiol Biochem       Date:  2013-12-18

8.  Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver.

Authors:  Alexander Krause; Rannar Sillard; Burkhard Kleemeier; Enno Klüver; Erik Maronde; José Ramon Conejo-García; Wolf Georg Forssmann; Peter Schulz-Knappe; Michael C Nehls; Frank Wattler; Sigrid Wattler; Knut Adermann
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

9.  Circulating prouroguanylin is processed to its active natriuretic form exclusively within the renal tubules.

Authors:  Xun Qian; Nicholas G Moss; Robert C Fellner; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

10.  Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide.

Authors:  Nicholas G Moss; Robert C Fellner; Xun Qian; Sharon J Yu; Zhiping Li; Masamitsu Nakazato; Michael F Goy
Journal:  Endocrinology       Date:  2008-05-22       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.